2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
54
Neoplasms
38
Lung Neoplasms
24
Colorectal Neoplasms
24
Prostatic Neoplasms
17
Uterine Cervical Neoplasms
14
Motor Activity
13
Colonic Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Rectal Neoplasms
9
Pancreatic Neoplasms
9
Hematologic Neoplasms
9
Anxiety Disorders
9
Urinary Bladder Neoplasms
8
Obesity
8
Melanoma
8
Lymphoma
8
Depression
8
Ovarian Neoplasms
7
Endometrial Neoplasms
7
Vulvar Neoplasms
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Breast Carcinoma In Situ
6
Sarcoma
5
Papillomavirus Infections
5
Pain
5
Leukemia, Myeloid, Acute
5
Hematopoietic and Lymphatic System Neoplasm
5
Triple Negative Breast Neoplasms
4
Interventions
Surveys and Questionnaires
3
Standard of Care
3
erythromycin propionate-N-acetylcysteinate
1
Therapeutics
1
Surgical Procedures, Operative
1
Quality Assurance, Health Care
1
Practice Guidelines as Topic
1
Palliative Care
1
Midazolam
1
Methods
1
Metformin
1
Mass Screening
1
Interviews as Topic
1
Genes, p53
1
Focus Groups
1
Exercise
1
Dignity Therapy
1
Diet
1
Dexmedetomidine
1
Coping Skills
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Death
×
Methods
×
Clear all
NCT00106067
2015-04-07
A&SC
VA Office of Research and Development
Phase NA
Completed
559 enrolled